BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28737909)

  • 1. Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers.
    Anthony NG; Baiget J; Berretta G; Boyd M; Breen D; Edwards J; Gamble C; Gray AI; Harvey AL; Hatziieremia S; Ho KH; Huggan JK; Lang S; Llona-Minguez S; Luo JL; McIntosh K; Paul A; Plevin RJ; Robertson MN; Scott R; Suckling CJ; Sutcliffe OB; Young LC; Mackay SP
    J Med Chem; 2017 Aug; 60(16):7043-7066. PubMed ID: 28737909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway.
    Tian F; Zhou P; Kang W; Luo L; Fan X; Yan J; Liang H
    J Recept Signal Transduct Res; 2015; 35(4):307-18. PubMed ID: 25386663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IKKα plays a major role in canonical NF-κB signalling in colorectal cells.
    Prescott JA; Balmanno K; Mitchell JP; Okkenhaug H; Cook SJ
    Biochem J; 2022 Feb; 479(3):305-325. PubMed ID: 35029639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen.
    Lam LT; Davis RE; Ngo VN; Lenz G; Wright G; Xu W; Zhao H; Yu X; Dang L; Staudt LM
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20798-803. PubMed ID: 19104039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IKKalpha and IKKbeta each function to regulate NF-kappaB activation in the TNF-induced/canonical pathway.
    Adli M; Merkhofer E; Cogswell P; Baldwin AS
    PLoS One; 2010 Feb; 5(2):e9428. PubMed ID: 20195534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant IkappaB kinases alpha and beta are direct kinases of Ikappa Balpha.
    Li J; Peet GW; Pullen SS; Schembri-King J; Warren TC; Marcu KB; Kehry MR; Barton R; Jakes S
    J Biol Chem; 1998 Nov; 273(46):30736-41. PubMed ID: 9804849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of thienopyrimidine-based FLT3 inhibitors from the structural modification of known IKKβ inhibitors.
    Park CH; Lee C; Yang JS; Joe BY; Chun K; Kim H; Kim HY; Kang JS; Lee JI; Kim MH; Han G
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2655-60. PubMed ID: 24813730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IKKα-dependent non-canonical pathway of NF-κB activation is constitutively active and modulates progression-related functions in a subset of human melanomas.
    Dewert N; Amschler K; Lorenz V; Schön MP
    Arch Dermatol Res; 2016 Dec; 308(10):733-742. PubMed ID: 27744496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro Evidences.
    Patil KR; Mohapatra P; Patel HM; Goyal SN; Ojha S; Kundu CN; Patil CR
    PLoS One; 2015; 10(5):e0125709. PubMed ID: 25938234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected].
    Penzo M; Molteni R; Suda T; Samaniego S; Raucci A; Habiel DM; Miller F; Jiang HP; Li J; Pardi R; Palumbo R; Olivotto E; Kew RR; Bianchi ME; Marcu KB
    J Immunol; 2010 Apr; 184(8):4497-509. PubMed ID: 20231695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of pyrrolopyrimidine inhibitors of Akt.
    Blake JF; Kallan NC; Xiao D; Xu R; Bencsik JR; Skelton NJ; Spencer KL; Mitchell IS; Woessner RD; Gloor SL; Risom T; Gross SD; Martinson M; Morales TH; Vigers GP; Brandhuber BJ
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5607-12. PubMed ID: 20810279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.
    Farhana L; Dawson MI; Murshed F; Fontana JA
    Cell Death Differ; 2011 Jan; 18(1):164-73. PubMed ID: 20671747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKε kinases.
    McIver EG; Bryans J; Birchall K; Chugh J; Drake T; Lewis SJ; Osborne J; Smiljanic-Hurley E; Tsang W; Kamal A; Levy A; Newman M; Taylor D; Arthur JS; Clark K; Cohen P
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7169-73. PubMed ID: 23099093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin.
    Tapia MA; González-Navarrete I; Dalmases A; Bosch M; Rodriguez-Fanjul V; Rolfe M; Ross JS; Mezquita J; Mezquita C; Bachs O; Gascón P; Rojo F; Perona R; Rovira A; Albanell J
    Cell Cycle; 2007 Sep; 6(18):2284-92. PubMed ID: 17890907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
    Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization and biological evaluation of aminopyrimidine-based IκB kinase β inhibitors with potent anti-inflammatory effects.
    Shin Y; Lim SM; Yan HH; Jung S; Fang Z; Jung KH; Hong SS; Hong S
    Eur J Med Chem; 2016 Nov; 123():544-556. PubMed ID: 27517803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implications.
    Hideshima T; Chauhan D; Kiziltepe T; Ikeda H; Okawa Y; Podar K; Raje N; Protopopov A; Munshi NC; Richardson PG; Carrasco RD; Anderson KC
    Blood; 2009 May; 113(21):5228-36. PubMed ID: 19270264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of novel
    Xie X; Tu J; You H; Hu B
    Drug Des Devel Ther; 2017; 11():1439-1451. PubMed ID: 28553074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation.
    Solt LA; Madge LA; May MJ
    J Biol Chem; 2009 Oct; 284(40):27596-608. PubMed ID: 19666475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.